Nakagomi, Atsushi
Okada, Sho
Shoji, Toshihiro
Kobayashi, Yoshio
Article History
Received: 12 April 2016
Revised: 7 July 2016
Accepted: 4 August 2016
First Online: 20 October 2016
Competing interests
: YK received lecture fees from Daiichi-Sankyo (Tokyo, Japan), Takeda Pharmaceutical (Osaka, Japan), Bayer Yakuhin (Osaka, Japan) and Boehringer Ingelheim (Ingelheim, Germany). YK received research grants from Boehringer Ingelheim (Ingelheim, Germany), Pfizer (New York, USA), Otsuka Pharmaceutical (Tokyo, Japan), Takeda Pharmaceutical (Osaka, Japan), Mitsubishi Tanabe Pharma (Osaka, Japan), Sumitomo Dainippon Pharma (Osaka, Japan), Astellas Pharma (Tokyo, Japan), St Jude Medical (St Paul, USA), Abbott Vascular Japan (Tokyo, Japan) and Daiichi-Sankyo (Tokyo, Japan). All other authors declare no conflicts of interest.
Free to read: This content has been made available to all.